SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Teva Acquires Worldwide Rights to BXCL501

Story updates

12:04:47 PM UTC
SquawkNews
Teva completed the acquisition of BioXcel Therapeutics (BTAI) neuroscience assets, including worldwi

Related stories